A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: The improved study

Annals of the Rheumatic Diseases

Volumn 73, Issue 7, 2014, Pages 1356-1361

  Heimans, L ^a   Wevers de Boer, K V C ^a   Visser, K ^a   Goekoop, R J ^b   Van Oosterhout, M ^c   Harbers, J B ^d   Bijkerk, C ^e   Speyer, I ^f   De Buck, M P D M ^f   De Sonnaville, P B J ^g   Grillet, B A M ^e   Huizinga, T W J ^a   Allaart, C F ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HAGA HOSPITAL   (Netherlands)

^c GROENE HART HOSPITAL   (Netherlands)

^d Franciscus Hospital   (Netherlands)

^e Department of Rheumatology Reinier de Graaf Gasthuis ^*  (Netherlands)

^f MEDICAL CENTER HAAGLANDEN   (Netherlands)

^g Admiraal de Ruyter Hospital   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIRHEUMATIC AGENT; HYDROXYCHLOROQUINE; LIVER ENZYME; METHOTREXATE; PREDNISONE; SALAZOSULFAPYRIDINE;

ADULT; ARTHRITIS; ARTICLE; BRONCHITIS; CARDIOVASCULAR DISEASE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE ACTIVITY SCORE; DIZZINESS; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG MEGADOSE; FEMALE; FEVER; FUNCTIONAL STATUS; GASTROINTESTINAL INFECTION; GASTROINTESTINAL TOXICITY; HAIR DISEASE; HAIR LOSS; HUMAN; INFECTION; INFECTIOUS PNEUMONIA; INFLUENZA; INJURY; JOINT RADIOGRAPHY; LIVER TOXICITY; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MOOD DISORDER; MUCOSAL DISEASE; MULTICENTER STUDY; NAUSEA; OPEN STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOPATHY; RANDOMIZED CONTROLLED TRIAL; REMISSION; RHEUMATOID ARTHRITIS; SINGLE BLIND PROCEDURE; SKIN INFECTION; SKIN TOXICITY; TREATMENT PLANNING; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; UROGENITAL TRACT DISEASE; VOMITING;

ANTI-TNF; DMARDS (SYNTHETIC); EARLY RHEUMATOID ARTHRITIS;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; EARLY MEDICAL INTERVENTION; FEMALE; HUMANS; HYDROXYCHLOROQUINE; MALE; METHOTREXATE; MIDDLE AGED; PREDNISONE; REMISSION INDUCTION; SINGLE-BLIND METHOD; SULFASALAZINE; TREATMENT OUTCOME;

EID: 84902245923     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-203243     Document Type: Article

References (28)

1. Mottonen T, Hannonen P, Leirisalo-Repo M, et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: A randomised trial. FIN-RACo trial group. Lancet 1999;353:1568-73. (Pubitemid 29219206)
2. Welsing PM, van Gestel AM, Swinkels HL, et al. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum 2001;44:2009-17. (Pubitemid 33644042)
3. Welsing PM, Landewe RB, van Riel PL, et al. The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: A longitudinal analysis. Arthritis Rheum 2004;50:2082-93. (Pubitemid 38924385)
4. Klareskog L, van der Heijde D, de Jager JP, et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 2004;363:675-81. (Pubitemid 38296553)
5. Lipsky PE, van der Heijde DM, St Clair EW, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. N Engl J Med 2000;343:1594-602.
6. Boers M, Verhoeven AC, Markusse HM, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997;350:309-18. (Pubitemid 27351112)
7. Verpoort KN, van Dongen H, Allaart CF, et al. Undifferentiated arthritis-disease course assessed in several inception cohorts. Clin Exp Rheumatol 2004;22:S12-S17. (Pubitemid 39328351)
8. Wevers-de Boer K, Visser K, Heimans L, et al. Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study). Ann Rheum Dis 2012;71:1472-7.
9. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial. Arthritis Rheum 2008;58:S126-35.
10. Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010;69:1580-8.
11. Felson DT, Smolen JS, Wells G, et al. American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis 2011;70:404-13.
12. Siegert CE, Vleming LJ, Vandenbroucke JP,, et al. Measurement of disability in Dutch rheumatoid arthritis patients. Clin Rheumatol 1984;3:305-9. (Pubitemid 15072110)
13. Prevoo ML, van Gestel AM, van't Hof M, et al. Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol 1996;35:1101-5.
14. van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 2000;27:261-3. (Pubitemid 30058662)
15. Shrout PE,, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86:420-8.
16. Breedveld FC, Weisman MH, Kavanaugh AF, et al. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 2006;54:26-37. (Pubitemid 43122183)
17. Grigor C, Capell H, Stirling A, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): A single-blind randomised controlled trial. Lancet 2004;364:263-9. (Pubitemid 38942816)
18. Makinen H, Kautiainen H, Hannonen P, et al. Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis. J Rheumatol 2007;34:316-21.
19. van der Heijde D, Klareskog L, Rodriguez-Valverde V, et al. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: Two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial. Arthritis Rheum 2006;54:1063-74. (Pubitemid 43672919)
20. Willemze A, van der Linden MP, le Cessie S, et al. The window of opportunity in ACPA-positive rheumatoid arthritis is not explained by ACPA characteristics. Ann Rheum Dis 2011;70:1697-8.
21. Zeidler H. The need to better classify and diagnose early and very early rheumatoid arthritis. J Rheumatol 2012;39:212-17.
22. Keystone E, Freundlich B, Schiff M, et al. Patients with moderate rheumatoid arthritis (RA) achieve better disease activity states with etanercept treatment than patients with severe RA. J Rheumatol 2009;36:522-31.
23. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, et al. Comparison of treatment strategies in early rheumatoid arthritis: A randomized trial. Ann Intern Med 2007;146:406-15. (Pubitemid 351650575)
24. Klarenbeek NB, Guler-Yuksel M, van der Kooij SM, et al. The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the Best study. Ann Rheum Dis 2011;70:1039-46.
25. de Jong PH, Hazes JM, Barendregt PJ, et al. Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial. Ann Rheum Dis 2013;72:72-8.
26. Wiens A, Venson R, Correr CJ. Meta-analysis of the efficacy and safety of adalimumab, etanercept, and infliximab for the treatment of rheumatoid arthritis. Pharmacotherapy 2010;30:339-53.
27. Navarro-Sarabia F, Ariza-Ariza R, Hernandez-Cruz B, et al. Adalimumab for treating rheumatoid arthritis. Cochrane Database Syst Rev 2005;CD005113.
28. van der Kooij SM, le Cessie S, Goekoop-Ruiterman YP, et al. Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis. Ann Rheum Dis 2009; 68:1153-8.